Prestige Biologics Co., Ltd. (KOSDAQ: 334970)
South Korea
· Delayed Price · Currency is KRW 4,810.00
+10.00 (0.21%)
Jan 22, 2025, 9:00 AM KST
Prestige Biologics Revenue
Prestige Biologics had revenue of 342.27M KRW in the quarter ending September 30, 2024, a decrease of -62.57%. This brings the company's revenue in the last twelve months to 1.60B, up 10,158.50% year-over-year. In the fiscal year ending June 30, 2024, Prestige Biologics had annual revenue of 2.17B with 24.24% growth.
Revenue (ttm)
1.60B
Revenue Growth
+10,158.50%
P/S Ratio
185.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
371.60B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 292.86T |
| SK hynix | 57.73T |
| LG Energy Solution | 27.17T |
| Samsung Biologics Co.,Ltd. | 4,364.39B |
| Hyundai Motor Company | 170.28T |
| Kia Corporation | 104.63T |
| Celltrion | 2,876.25B |
| KB Financial Group | 14.11T |